Last update: 3:15 p.m. EDT Oct. 29, 2008
EAST LONGMEADOW, Mass., Oct 29, 2008 /PRNewswire via COMTEX/ -- Texcel, a leading provider of custom medical device development and manufacturing solutions, has introduced its innovative new StimX programmable, implantable stimulation system.
Designed for use in the research and development of specialty stimulation therapies, the StimX system is the industry's first-truly programmable, implantable customizable platform.
The StimX system's programmable stimulation parameters "will directly benefit medical researchers and medical device developers by dramatically reducing the time, cost, and risk involved in creating devices for use in testing stimulation therapies in a variety of applications," said Keith Checca, Texcel Director of Business Development.
"With the StimX implantable system, we are freeing researchers from the hours and dollars that they'd otherwise invest in designing and developing their own devices -- and to literally re-allocate their resources back into their research," said Checca.
Neural stimulation therapies, including direct nerve and brain stimulation, are used to treat people who suffer from epilepsy, Parkinson's disease, clinical depression and other diseases. Targeted stimulation areas range widely from direct brain surface, deep brain stimulation, to the spinal cord and peripheral nerves.
Texcel's new StimX platform includes an implantable stimulator, laptop and output customization program, proven wireless communication and charging modules.
The need for the system was realized as a result of Texcel's years of innovation in the field of custom medical device manufacturing and it was made possible by Texcel's partnerships with medical electronics development resources.
For more information, visit the Texcel website at: http://www.texcelmedical.com/stimx; or call the company at (413) 525-5700.